[go: up one dir, main page]

SEvAl, 2012 - Google Patents

Combined axillary bloCk with “seleCtive” injeCtion of nerves and the axillary Catheter: Comparison of bupivaCaine 0.25% or levobupivaCaine 0.25% EMİNE Al …

SEvAl, 2012

View PDF
Document ID
5212274237116558223
Author
SEvAl K
Publication year

External Links

Snippet

Purpose: the aim of this study is to apply combination of axillary plexus block with “selective” injection of nerves and continuous catheter technique, and to compare the anesthetic and postoperative analgesic effects of bupivacaine and levobupivacaine. Methods: In 30 …
Continue reading at www.aub.edu.lb (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3401—Puncturing needles for the peridural or subarachnoid space or the plexus, e.g. for anaesthesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
    • A61B2505/05—Surgical care

Similar Documents

Publication Publication Date Title
Shrestha et al. Comparative study between tramadol and dexamethasone as an admixture to bupivacaine in supraclavicular brachial plexus block
Kim et al. Dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery
Ammar et al. Does the addition of magnesium to bupivacaine improve postoperative analgesia of ultrasound-guided thoracic paravertebral block in patients undergoing thoracic surgery?
Aguilar et al. Absence of an early pre-emptive effect after thoracic extradural bupivacaine in thoracic surgery.
Pongraweewan et al. Onset time of 2% lidocaine and 0.5% bupivacaine mixture versus 0.5% bupivacaine alone using ultrasound and double nerve stimulation for infraclavicular brachial plexus anesthesia in ESRD patients undergoing arteriovenous fistula creation
Nema et al. Effect of addition of dexmedetomidine to ropivacaine hydrochloride (0.75%) in brachial plexus block through supraclavicular route in upper limb surgeries: a clinical comparative study
Ertug et al. Comparison of two different techniques for brachial plexus block: infraclavicular versus axillary technique
Özmen et al. The effect of addition of lidocaine to bupivacaine on anesthesia beginning time, block time, and block quality in lateral sagittal infraclavicular block
SEvAl Combined axillary bloCk with “seleCtive” injeCtion of nerves and the axillary Catheter: Comparison of bupivaCaine 0.25% or levobupivaCaine 0.25% EMİNE Al, lÜTFİYE PİRBUDAK, NURSAN TAhTAcı
Madhusudhanan et al. Effect of nalbuphine as adjuvant to 0.5% bupivacaine in ultrasoundguided supraclavicular brachial plexus block
Patil et al. Evaluation and comparison of intravenous clonidine and intravenous dexmedetomidine on duration of bupivacaine spinal anesthesia
AL et al. COMBİNED AXİLLARY BLOCK WİTH “SELECTİVE” İNJECTİON OF NERVES AND THE AXİLLARY CATHETER: COMPARİSON OF BUPİVACAİNE 0.25% OR LEVOBUPİVACAİNE 0.25%
Saini et al. Comparison of analgesic efficacy of ultrasound-guided interscalene block versus continuous subacromial infusion for postoperative analgesia following arthroscopic rotator cuff repair surgeries: a randomized trial
Chauhan et al. Comparison of block characteristics and postoperative analgesia of 0.5% levobupivacaine with 0.5% ropivacaine in ultrasound guided supraclavicular block for orthopedic forearm surgery-A prospective, comparative, randomized, clinical study
Zhao et al. Efficacy of low dose levobupivacaine (0.1%) for axillary plexus block using multiple nerve stimulation
Dikmen et al. The effects of adding tramadol to ropivacaine on axillary brachial plexus blockade in uremic patients
Muhammed Comparision of Dexmedetomidine as an Adjuvant to Levobupivacaine Versus Levobupivacaine (Plain) in Supra Clavicular Brachial Plexus Block: A Clinical Study
Borgohain et al. Efficacy of Magnesium Sulphate as Adjuvant to Bupivacaine 0.5% for Supraclavicular Brachial Plexus Block in Patients undergoing Upper Limb Surgery.
Mekkawy et al. Atracurium mixed with magnesium sulfate versus atracurium alone as adjuvant to lidocaine in intravenous regional anesthesia
Ziabari Local Anesthetics
Bhaire et al. A prospective randomized controlled study comparing efficacy of dexmedetomidine versus dexamethasone as an adjuvant to 0.75% ropivacaine in supraclavicular brachial plexus block under ultrasound guidance forearm and hand surgeries
Akshay et al. Clinical Comparative Evaluation of Bupivacaine with Fentanyl and Ropivacaine with Fentanyl in Upper Limb Surgery Under Supra Clavicular Brachial Block
Das et al. Clinical comparison of analgesic efficacy of addition of injection dexamethasone 8mg to 20ml 0.5% levobupivacaine in ultrasonography assisted supraclavicular brachial plexus block
Vemuri et al. Section: Anaesthesiology
Salem et al. Dexamethasone and Ketorolac as an adjuvant to Bupivacaine in axillary block for distal upper limb surgeries